Michael Lidsky, MD, FACS
@michael_lidsky
Followers
1K
Following
3K
Statuses
463
Surgical Oncologist and Hepatopancreatobiliary Surgeon @DukeSurgery, Basic and Translational Surgeon-Scientist @DukeUniversity @DukeSurgOnc
Durham, NC
Joined May 2020
RT @eaonc: #ClinicalTrial EA2222/PUMP, led by @michael_lidsky, is a randomized phase 3 study of #SystemicTherapy with or without hepatic a…
0
1
0
RT @sepideh_gholami: Please join us for the next @AHPBA clinical trial webinar discussing endpoints! Great speakers lined up! @DrMikeCavna…
0
7
0
Congrats @DenboJw
It has been a great experience working with our talented multidisciplinary team @MoffittNews over the last 5 years…excited about the next 5! @BiachiTiago @DanielAnayaMD @MoffittNews @NaineshParikhMD @JessicaFrakesMD @ml4onco @PatrickHwuMD @karenluMD @MHepatobiliary @RejniakLab
0
0
8
RT @eaonc: EA2197 is a randomized phase 2/3 #ClinicalTrial assessing the optimal perioperative approach for patients with incidental #Gallb…
0
3
0
RT @DianeReidyLagun: I am elated and tremendously honored to be joining @dukemedicine @DukeHealth family where there’s so much talent, inno…
0
10
0
Exciting things are happening @DukeCancer !! Can’t wait for @DianeReidyLagun to join the Duke family! @DukeSurgOnc @PeterAllenMD @DukeHealth @DukeMedSchool @DukeHospital
Diane Reidy-Lagunes, MD, will join @dukemedicine as chief of the Division of Medical Oncology, effective April 1, 2025. Reidy-Lagunes will also hold an appointment as Associate Vice President for Oncology Services for @DukeHealth. @DukeMedSchool
1
4
32
RT @SocSurgOnc: Don’t miss the ACT Keynote: 'Surgeon Scientists in the U.S.: A Bright Future' by Martha Zeiger, MD, FACS! #ACT2025 offers a…
0
2
0
RT @eaonc: #ClinicalTrial EA2222/PUMP, led by @michael_lidsky, is a randomized phase 3 study of #SystemicTherapy with or without hepatic a…
0
3
0
RT @DukeCancer: Neoadjuvant therapy is shown to improve outcomes for patients with advanced-stage #Melanoma. DCI members wrote for @ASCO ab…
0
7
0
RT @AlexandriaSoto_: Kicked off the 6th Annual ASPIRES Program with 1st year URiM students & @DukeSurgery faculty! Key takeaway: Mentorsh…
0
8
0
RT @eaonc: Could chemotherapy given both before and after surgery improve outcomes for patients with #GallbladderCancer (compared to chemo…
0
3
0
RT @FlavioRochaMD: Announcing 🗣️ our named speakers #AHPBA25 Register today 💻 to reserve your spot @AHPBA
0
10
0
RT @eaonc: #ClinicalTrial EA2222/PUMP, led by @michael_lidsky, is a randomized phase 3 study of #SystemicTherapy with or without hepatic a…
0
5
0
RT @DukeSurgOnc: Thank you to all our faculty, fellows, friends and collaborators who made 2024 a wonderful and successful year! 🥂 We wish…
0
4
0
I highly recommend this meeting for anyone in the advanced cancer therapeutics space! Great content planned for #HPB, #melanoma, #trials, and of course #peritonealsurfacemalignancies | Hope to see you there! @SocSurgOnc @DukeSurgOnc @pmppalsnetwork @colontown @FightCRC
#ACT2025 serves as a comprehensive forum to promote research, development and application of advanced cancer therapies. This event promotes education and the exchange of information among professionals regarding advanced cancer therapies. Join us:
0
4
19
RT @eaonc: .@michael_lidsky of @DukeSurgOnc and @DukeCancer is leading EA2222/PUMP, a randomized phase 3 study for patients with #Colorecta…
0
2
0
RT @eaonc: In #ClinicalTrial EA2222/PUMP, investigators are testing #PumpChemo in addition to SOC chemo versus SOC chemo alone for patients…
0
2
0
Congrats @globalsurgallie , amazing accomplishment, especially only 1 year into your career! Looking forward to watching your meteoric career! Lucky to have you as partner @DukeSurgOnc and @DukeSurgery , but even luckier to have you as a friend!
So grateful to my friends & mentors who support me both personally and professionally & who helped me secure my first independent funding with @Duke_CTSI. Cannot wait to begin this work to support rural communities to care for patients w/ liver cancer. @DukeSurgOnc @DukeSurgery
0
2
16
RT @CathyEngMD: @VUMC_Cancer @VUMCDiscoveries We are delighted to be participating in @eaonc #EA2222 a phase III clinical trial led by nat…
0
3
0
RT @eaonc: #ClinicalTrial EA2222/PUMP, led by @michael_lidsky, is a randomized phase 3 study of #SystemicTherapy with or without hepatic a…
0
1
0